Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 3 20Phase NA 7Phase 4 4Phase 1/2 4Phase 1 4Phase 2/3 2Phase EARLY_PHASE1 1

Status

Terminated 2

Sponsor Class

OTHER 11INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 81Thoracic 49Genitourinary 30Breast 28Other hematologic neoplasm 26Lymphoid 23Gynecologic 20Head & Neck 17Dermatologic 13Myeloid 12Sarcoma 10CNS 10Plasma cell 7Tumor-Agnostic 5Endocrine 5Other solid neoplasm 4Other 2NET 2Classical hematology 2

Conditions

Stomatitis 1Oropharyngeal Neoplasms 1Oral Ulcer 1Opioid-Induced Constipation 1Mucositis 1Head and Neck Neoplasms 1Constipation 1

Interventions

tegaserod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × INDUSTRY × Other × Clear all
NCT04648020 2023-05-31

VOICE

Monopar Therapeutics

Phase 2/3 Terminated
190 enrolled
Head & NeckOther

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Stomatitis, Oral Ulcer, Mucositis

NCT00365820 2012-04-20

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

Novartis

Phase 2/3 Terminated
670 enrolled
Other

Opioid-Induced Constipation, Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡